HRT Patch vs Pill vs Gel: Choosing the Right Delivery Method

Oral pills (estradiol tablets, conjugated equine estrogens like Premarin) deliver estrogen through the gut and liver. Transdermal patches (Climara, Vivelle-Dot, Estradot) stick to the skin and deliver estradiol over 3–7 days. Gels and sprays (Estrogel, Divigel, Evamist, Lenzetto) are applied daily to the skin. Vaginal rings, creams, and tablets deliver estrogen primarily for genitourinary symptoms with minimal systemic absorption. For women needing systemic relief from hot flashes, mood, and bone protection, the systemic options (pills, patches, gels, sprays) are equivalent in symptom control — but differ meaningfully in safety profile.

Oral estrogen passes through the liver before reaching the rest of the body — the first-pass effect. The liver converts some estrogen and increases production of clotting factors, sex-hormone-binding globulin (SHBG), and triglycerides. This is why oral estrogen modestly raises venous thromboembolism (VTE) and stroke risk. Transdermal estrogen is absorbed directly into the bloodstream and does not raise clotting factors. Multiple observational studies, including a large French cohort (E3N) and a 2019 BMJ analysis, found transdermal HRT carries no increase in VTE compared with non-users. For women with elevated baseline clot risk — older age, migraine, higher BMI, history of clot — transdermal is strongly preferred.

If you have a uterus, you need progesterone alongside estrogen to protect the endometrium from hyperplasia and cancer. Oral micronized progesterone (brand: Prometrium; generic: bioidentical) is the modern preferred option. The WHI 30-year follow-up, published in JAMA in 2024, suggested that the increased breast cancer risk seen in the original WHI was largely driven by the synthetic progestin medroxyprogesterone acetate (MPA) rather than estrogen alone. Oral micronized progesterone may have a more favorable risk profile. It also has mild sedating effects, which many women appreciate when taken at bedtime — improving sleep alongside hormone replacement.

All systemic forms — pill, patch, gel, spray — control vasomotor symptoms similarly when properly dosed. Patches give the most stable blood levels (less peak/trough variability), which some women find produces more consistent symptom relief and fewer breakthrough hot flashes. Gels and sprays are easier to fine-tune dose-by-dose and avoid skin irritation that some patch users get. Pills are cheapest, easiest, and most familiar — but with the higher clot/stroke risk profile. For mood and brain fog, patches are often preferred because of consistent levels, though high-quality head-to-head data are limited.

Generic estradiol pills are typically the cheapest option ($5–15/month with insurance). Generic patches run $20–60/month. Estradiol gel is $25–80/month. Brand-name versions are dramatically more expensive, often $200–400/month without insurance. Many telehealth menopause clinics — like Midi Health, Alloy, and Evernow — bundle prescription and shipping at competitive prices. Compounded bioidentical hormones, often pitched as 'safer' or 'more natural,' typically cost more and are not FDA-approved; bioidentical estradiol patches and oral micronized progesterone are already FDA-approved and bioidentical, so most women don't need compounded products.

Personal history changes the calculus. Prior VTE, current smoker, or migraine with aura generally rule out oral estrogen but transdermal may still be considered with specialist guidance. Active or recent estrogen-sensitive breast cancer is a contraindication to systemic HRT — but vaginal estrogen for genitourinary symptoms is often still appropriate after discussion with oncology. Family history alone (without personal clot or breast cancer) is not a contraindication. Triple-negative breast cancer history has more flexibility than ER+ disease. These conversations are highly individualized — work with a menopause-experienced clinician rather than relying on broad rules.